Featured series 
-
HealthJust who gets a say at FDA public drug-approval hearings?
New research shows negative voices are relatively rare in drug approval hearings.
-
Nation & WorldWhat’s working, not on front lines of AI in classroom
Tech, education experts share new initiatives on learner profiles, making STEM more accessible, ‘microschool’ experiments
-
HealthHow a toxin from the gut microbiome may help spark colorectal cancer
Findings suggest colibactin may be promising target for disease prevention
-
Science & TechCracking the code of why, when some choose to ‘self-handicap’
New research also offers hints for devising ways to stop students from creating obstacles to success
-
Work & EconomyDoes ‘work from anywhere’ really work?
Take our research-based quiz to test your knowledge of office culture trends
Quiz
-
HealthYour digital twin might save your life
AI, statistics offer new possibilities for personalized medicine
-
Health‘This is it. This is exactly what I want to do.’
Michael VanRooyen started running toward trouble more than 30 years ago. He’s still going.
Part of the Experience series
-
Science & TechHow memory works (and doesn’t)
In podcast, scientists explain why remembering is more reconstruction than replay
Podcast
